170846-74-9
170846-74-9
Chemical Structure
CHPG
- CAS No.: 170846-74-9
- Formula:C8H8ClNO3
- Molecular Weight:201.61
IUPAC Name: 2-amino-2-(2-chloro-5-hydroxyphenyl)acetic acid
InChIKey: UNIDAFCQFPGYJJ-UHFFFAOYSA-N
SMILES: O=C(O)C(N)C1=CC(O)=CC=C1Cl
Biological Activity: CHPG is a selective mGluR5 agonist, and attenuates SO2-induced oxidative stress and inflammation through TSG-6/NF-κB pathway in BV2 microglial cells[1]. CHPG protects against traumatic brain injury (TBI) in vitro and in vivo by activation of the ERK and Akt signaling pathways[2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
CHPG | 99.66% | CHPG is a selective mGluR5 agonist, and attenuates SO2-induced oxidative stress and inflammation through TSG-6/NF-κB pathway in BV2 microglial cells. CHPG protects against traumatic brain injury (TBI) in vitro and in vivo by activation of the ERK and Akt signaling pathways. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Structural Analogs
-
Similarity Score 0.87
HY-101364ARCHPG sodium salt (Standard) -
Similarity Score 0.86
HY-W0022352-Chlorophenylglycine -
Similarity Score 0.86
HY-W050023(S)-2-Amino-2-(2-chlorophenyl)acetic acid -
Similarity Score 0.86
HY-100841(Rac)-3-Hydroxyphenylglycine -
Similarity Score 0.86
HY-100841A(S)-3-Hydroxyphenylglycine -
Similarity Score 0.85
HY-W0411713-Chloro-L-tyrosine -
Similarity Score 0.85
HY-W041171S3-Chloro-L-tyrosine-13C6 -
Similarity Score 0.84
HY-34588D-4-Hydroxyphenylglycine -
Similarity Score 0.84
HY-W0052262-Amino-2-(4-hydroxyphenyl)acetic acid -
Explore the MedChemAI to find more analogs
References
- [1]. Qiu JL, et al. The selective mGluR5 agonist CHPG attenuates SO2-induced oxidative stress and inflammation through TSG-6/NF-κB pathway in BV2 microglial cells. Neurochem Int. 2015 Jun-Jul;85-86:46-52. [Content Brief]
- [2]. Chen T, et al. The selective mGluR5 agonist CHPG protects against traumatic brain injury in vitro and in vivo via ERK and Akt pathway. Int J Mol Med. 2012 Apr;29(4):630-6. [Content Brief]
